Table 3.
HEAL metrics for cancer (3.A) and non-cancer (3.B) dermatologic conditions including health outcomes (DALYs per 100,000) and AI performances (top-3 agreement) across age groups. For cancer conditions, the youngest age group (20–24 yrs, 12.1 DALYs per 100,000) was excluded due to insufficient sample size (N = 1).
| 3. A Cancer conditions. | ||||||
|---|---|---|---|---|---|---|
| Age group (yrs) | N | Health outcomes |
AI tool performance |
HEAL metric | ||
| DALYs (per 100,000) | Ranking | Top-3 agreement (95% CI) | Ranking | |||
| 25–49 | 178 | 67.4 | 1 | 73.0% (65.9, 79.4) | 3 | R = 1.0 p (R >0) = 73.8% |
| 50–69 | 543 | 257.1 | 2 | 79.7% (76.1, 83.0) | 2 | |
| 70+ | 495 | 475.7 | 3 | 83.4% (79.9, 86.6) | 1 | |
| 3. B Non-cancer conditions | ||||||
|---|---|---|---|---|---|---|
| Age group (yrs) | N | Health outcomes |
AI tool performance |
HEAL metric | ||
| DALYs (per 100,000) | Ranking | Top-3 agreement (95% CI) | Ranking | |||
| 20–24 | 308 | 545.3 | 2 | 89.0% (84.9, 92.2) | 1 | R = −0.8 p (R >0) = 0.0% |
| 25–49 | 1763 | 538.6 | 1 | 79.4% (77.4, 81.2) | 2 | |
| 50–69 | 1509 | 685.5 | 3 | 71.2% (68.9, 73.5) | 3 | |
| 70+ | 623 | 943.0 | 4 | 62.1% (58.2, 65.9) | 4 | |